+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Asia Pacific OTC Drug and Dietary Supplement Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; Type; Form; Distribution Channel; and Country- Product Image
Asia Pacific OTC Drug and Dietary Supplement Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; Type; Form; Distribution Channel; and Country- Product Image
Sale

Asia Pacific OTC Drug and Dietary Supplement Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product; Type; Form; Distribution Channel; and Country

  • PDF Icon

    Report

  • 198 Pages
  • November 2020
  • Region: Asia Pacific
  • The Insight Partners
  • ID: 5231533
UP TO OFF until Jun 30th 2024
Description Jump to:
According to the publisher's new market research study on “OTC Drug and Dietary Supplement Market to 2027 - Asia Pacific Analysis and Forecast - by Product, Type, Form and Distribution Channel, the market is expected to reach US$ 96,156.8 million in 2027 from US$ 55,157.2 million in 2019; it is estimated to grow at a CAGR of 7.3% from 2020 to 2027. The report highlights trends prevailing in the Asia Pacific OTC Drug and Dietary Supplement Market and the drivers and restraints pertaining to the market growth.

Based on product, the Asia Pacific OTC drug and dietary supplement market is segmented into analgesics, cough and cold products, vitamins and dietary supplements, gastrointestinal products, antacids, ophthalmic products, sleep aids, oral care products, feminine care and other products. The vitamins and dietary supplements segment is estimated to register the highest CAGR in the market during the forecast period. Increasing applications of dietary supplement in immunity boosting and regular body maintenance are the factors boosting the market for the vitamins and dietary supplements segment.

The Asia Pacific OTC drug and dietary supplement market growth is mainly attributed to factors such as rising awareness among population about general health issues, and advantages of OTC drugs are expected to propel the growth of the market. However, stringent government regulation for OTC drugs across the Asian countries is the major factor hindering the market growth. COVID19 has affected the Asia Pacific countries which has led to high number of coronavirus cases. People are purchasing more immunity booster products available in the market to combat coronavirus effect.

GlaxoSmithKline plc; Sanofi; Johnson and Johnson Services, Inc; Abbott; AbbVie Inc; Bausch Health Companies Inc; Bayer AG; Procter & Gamble; Novartis AG, and Reckitt Benckiser Group Plc among others. are among the leading companies operating in the OTC Drug and Dietary Supplement Market.

Reasons to Buy
  • Saves and reduces time required for carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific OTC drug and dietary supplement market
  • Highlights key business priorities to assist companies in order to realign their business strategies
  • Highlights key findings and recommendations of crucial progressive industry trends in the Asia Pacific OTC drug and dietary supplement market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develops/modifies business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinizes in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it
  • Enhances the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution

Table of Contents

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific OTC Drug and Dietary Supplement Market - by Product
1.3.2 Asia Pacific OTC Drug and Dietary Supplement Market - by Type
1.3.3 Asia Pacific OTC Drug and Dietary Supplement Market - by Form
1.3.4 Asia Pacific OTC Drug and Dietary Supplement - by Distribution Channel
1.3.5 Asia Pacific OTC Drug and Dietary Supplement Market- by Region
2. OTC Drug and Dietary Supplement Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. OTC Drug and Dietary Supplement - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific
4.3 Expert Opinion
5. Asia Pacific OTC Drug and Dietary Supplement Market - Industry Dynamics
5.1 Market Drivers
5.1.1 Rising General Health Issues
5.1.2 Preference for OTC Drugs
5.2 Market Restraints
5.2.1 Stringent Government Regulations For OTC Drugs
5.3 Market Opportunities
5.3.1 Business Expansion Activities by Market Players to Offer Improved OTC Drugs
5.4 Future Trends
5.4.1 Preference of OTC Drugs for Minor Diseases
5.5 Impact Analysis
6. OTC Drug and Dietary Supplement Market - Regional Analysis
6.1 Asia Pacific OTC Drug and Dietary Supplement Market Revenue Forecast and Analysis
7. Asia Pacific OTC Drug and Dietary Supplement Market Analysis - by Product
7.1 Overview
7.2 OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
7.3 Cough and Cold Products
7.3.1 Overview
7.3.2 Cough and Cold Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.4 Vitamins and Dietary Supplements
7.4.1 Overview
7.4.2 Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.5 Analgesics
7.5.1 Overview
7.5.2 Analgesics: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.6 Gastrointestinal Products
7.6.1 Overview
7.6.2 Gastrointestinal Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.7 Sleep Aids
7.7.1 Overview
7.7.2 Sleep Aids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.8 Oral Care Products
7.8.1 Overview
7.8.2 Oral Care Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.9 Ophthalmic Products
7.9.1 Overview
7.9.2 Ophthalmic Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.10 Antacids
7.10.1 Overview
7.10.2 Antacids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.11 Feminine Care
7.11.1 Overview
7.11.2 Feminine Care: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
7.12 Others
7.12.1 Overview
7.12.2 Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
8. OTC Drug and Dietary Supplement Analysis - by Type
8.1 Overview
8.2 OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
8.3 Branded
8.3.1 Overview
8.3.2 Branded: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
8.4 Generic
8.4.1 Overview
8.4.2 Generic: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9. OTC Drug and Dietary Supplement Analysis - by Form
9.1 Overview
9.2 OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027, (%)
9.3 Tablets
9.3.1 Overview
9.3.2 Tablets: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.4 Capsules
9.4.1 Overview
9.4.2 Capsules: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.5 Powders
9.5.1 Overview
9.5.2 Powders: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.6 Ointments
9.6.1 Overview
9.6.2 Ointments: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.7 Liquid
9.7.1 Overview
9.7.2 Liquid: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
10. OTC Drug and Dietary Supplement Analysis - by Distribution Channel
10.1 Overview
10.2 OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027, (%)
10.3 Hospital and Retail Pharmacies
10.3.1 Overview
10.3.2 Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
10.4 Retail Stores
10.4.1 Overview
10.4.2 Retail Stores: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
10.5 Online Channels
10.5.1 Overview
10.5.2 Online Channels: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
11. OTC Drug and Dietary Supplement Analysis and Forecasts to 2027 - Geographical Analysis
11.1 Asia Pacific: OTC Drug and Dietary Supplement Market
11.1.1 Overview
11.1.2 Asia-Pacific: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.3 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.4 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.5 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.1.6 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.7 Asia-Pacific: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
11.1.8 China: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 China: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 China: OTC Drug and Dietary Supplement Market,, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.8.3 China: OTC Drug and Dietary Supplement Market,, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.8.4 China: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.1.8.5 China: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.9 Japan: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Japan: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Japan: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.9.3 Japan: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.9.4 Japan: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.1.9.5 Japan: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.10 India: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 India: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 India: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.10.3 India: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.10.4 India: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.1.10.5 India: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.11 South Korea: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.1 South Korea: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.2 South Korea: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.11.3 South Korea: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.11.4 South Korea: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.1.11.5 South Korea: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.12 Australia: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.1 Australia: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.2 Australia: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
11.1.12.3 Australia: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
11.1.12.4 Australia: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
11.1.12.5 Australia: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
12. Impact Of COVID-19 Pandemic On Global OTC Drug and Dietary Supplement Market
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13. Company Profiles
13.1 GlaxoSmithKline plc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sanofi
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Johnson and Johnson Services, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbott
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 AbbVie Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bausch Health Companies Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bayer AG
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Procter & Gamble
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Novartis AG
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Reckitt Benckiser Group Plc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 Glossary of Terms, OTC Drug and Dietary Supplement
List of Tables
Table 1. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 2. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 3. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
Table 4. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 5. China: OTC Drug and Dietary Supplement Market,, by Product - Revenue and Forecast to 2027 (USD Million)
Table 6. China: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 7. China: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
Table 8. China: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 9. Japan: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 10. Japan: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 11. Japan: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
Table 12. Japan: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 13. India: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 14. India: OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 15. India: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
Table 16. India: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 17. South Korea OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 18. South Korea OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 19. South Korea: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
Table 20. South Korea: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 21. Australia: OTC Drug and Dietary Supplement Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 22. Australia OTC Drug and Dietary Supplement Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 23. Australia: OTC Drug and Dietary Supplement Market, by Form - Revenue and Forecast to 2027 (USD Million)
Table 24. Australia: OTC Drug and Dietary Supplement Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
List of Figures
Figure 1. OTC Drug and Dietary Supplement Market Segmentation
Figure 2. OTC Drug and Dietary Supplement Segmentation - by Region
Figure 3. Asia Pacific OTC Drug and Dietary Supplement Market Overview
Figure 4. Analgesics Segment Held Largest Share of OTC Drug and Dietary Supplement
Figure 5. OTC Drug and Dietary Supplement Market in Germany to show Remarkable Growth during Forecast Period
Figure 6. Asia Pacific OTC Drug and Dietary Supplement Market - Leading Country Markets (US$ Million)
Figure 7. Asia Pacific PEST Analysis
Figure 8. OTC Drug and Dietary Supplement Impact Analysis of Driver and Restraints
Figure 9. Asia Pacific OTC Drug and Dietary Supplement Market - Revenue Forecast and Analysis-2019-2027
Figure 10. OTC Drug and Dietary Supplement Revenue Share, by Product (2019 and 2027)
Figure 11. Cough and Cold Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 12. Vitamins and Dietary Supplements: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 13. Analgesics: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 14. Gastrointestinal Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 15. Sleep Aids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 16. Oral Care Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 17. Ophthalmic Products: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 18. Antacids: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Feminine Care: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 21. OTC Drug and Dietary Supplement Revenue Share, by Type (2019 and 2027)
Figure 22. Branded: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Generic: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 24. OTC Drug and Dietary Supplement Share, by Form, 2019 and 2027 (%)
Figure 25. Tablets: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Capsules: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Powders: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 28. Ointments: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Liquid: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 31. OTC Drug and Dietary Supplement Share, by Distribution Channel, 2019 and 2027 (%)
Figure 32. Hospital and Retail Pharmacies: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 33. Retail Stores: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 34. Online Channels: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 35. Others: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (US$ Million)
Figure 36. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Key Country - Revenue (2019) (USD Million)
Figure 37. Asia-Pacific: OTC Drug and Dietary Supplement Market, Revenue and Forecast to 2027 (USD Million)
Figure 38. Asia-Pacific: OTC Drug and Dietary Supplement Market, by Country, 2019 & 2027 (%)
Figure 39. China: OTC Drug and Dietary Supplement Market, - Revenue and Forecast to 2027 (USD Million)
Figure 40. Japan: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
Figure 41. India: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
Figure 42. South Korea: OTC Drug and Dietary Supplement Market - Revenue and Forecast to 2027 (USD Million)
Figure 43. Australia: OTC Drug and Dietary Supplement - Revenue and Forecast to 2027 (USD Million)
Figure 44. Impact of COVID-19 Pandemic on OTC Drug and Dietary Supplement Market in Asia Pacifican Countries

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • GlaxoSmithKline plc.
  • Sanofi
  • Johnson and Johnson Services, Inc.
  • Abbott
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Procter & Gamble
  • Novartis AG
  • Reckitt Benckiser Group Plc

Related Topics

Related Reports

Over The Counter Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 - Product Image

Over The Counter Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • Report
  • 143 Pages
  • Global
From
Over the Counter (OTC) Drugs - Global Strategic Business Report - Product Image

Over the Counter (OTC) Drugs - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
OTC Drugs & Dietary Supplements Market Report 2024-2034 - Product Image

OTC Drugs & Dietary Supplements Market Report 2024-2034

  • Report
  • 337 Pages
  • Global
From
OTC Drug and Dietary Supplement Global Market Report 2024 - Product Image

OTC Drug and Dietary Supplement Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
OTC Protein Dietary Supplements Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to 2031 - Product Image

OTC Protein Dietary Supplements Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to 2031

  • Report
  • 156 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.